Stoke outlines Q3 2027 EMPEROR readout and plans NDA submission in second half 2027

• CEO Ian Smith said the quarter centered on EMPEROR execution, FDA alignment, and launch prep: "To date, approximately 110 of the 162 enrolled patients have completed their week 28 visit" and "approximately 20 patients have also

Seeking Alpha's Disclaimer: This article was automatically generated by an AI tool based on content available on the Seeking Alpha website, and has not been curated or reviewed by humans. Due to inherent limitations in using AI-based tools, the accuracy, completeness, or timeliness of such articles cannot be guaranteed. This article is intended for informational purposes only. Seeking Alpha does not take account of your objectives or your financial situation and does not offer any personalized investment advice. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank.